Cargando…

Genetic analysis of IRF6, a gene involved in craniofacial midline formation, in relation to pituitary and facial morphology of patients with idiopathic growth hormone deficiency

INTRODUCTION: Growth hormone is secreted by the pituitary gland, which forms part of the craniofacial midline. IRF6 encodes a transcription factor involved in the development of the craniofacial midline and mutations in IRF6 are known to disturb craniofacial development. Craniofacial and pituitary d...

Descripción completa

Detalles Bibliográficos
Autores principales: Starink, Eline, Hokken-Koelega, Anita C. S., Visser, Theo J., Baan, Janneke, Peeters, Robin P., de Graaff, Laura C. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606942/
https://www.ncbi.nlm.nih.gov/pubmed/28593555
http://dx.doi.org/10.1007/s11102-017-0808-8
_version_ 1783265214558371840
author Starink, Eline
Hokken-Koelega, Anita C. S.
Visser, Theo J.
Baan, Janneke
Peeters, Robin P.
de Graaff, Laura C. G.
author_facet Starink, Eline
Hokken-Koelega, Anita C. S.
Visser, Theo J.
Baan, Janneke
Peeters, Robin P.
de Graaff, Laura C. G.
author_sort Starink, Eline
collection PubMed
description INTRODUCTION: Growth hormone is secreted by the pituitary gland, which forms part of the craniofacial midline. IRF6 encodes a transcription factor involved in the development of the craniofacial midline and mutations in IRF6 are known to disturb craniofacial development. Craniofacial and pituitary development are closely related. After whole exome sequencing revealed a new mutation in IRF6 in a family with Idiopathic Growth Hormone Deficiency (IGHD), we screened the remainder of our IGHD cohort for mutations in this gene and related their genotypes to pituitary and craniofacial morphology. MATERIALS AND METHODS: We sequenced all coding exons and exon–intron boundaries of IRF6 in 81 patients with IGHD. We performed a multiplex ligation-dependent probe amplification (MLPA) in order to exclude copy number variations in IRF6. We analyzed facial measurements taken from standardized digital pictures of 48 patients. RESULTS: We found two new variants and eleven polymorphisms. Apart from the new mutation found in the index family (p.Arg233Cys), we found one other new heterozygous missense mutation in IRF6 (Pro456Ser). p.Arg233Cys was reported as extremely rare in exome databases (1 allele out of 120.852 alleles sequenced), strictly conserved among species and was predicted deleterious by all variant predictor programs. Pro456Ser was predicted to be benign. MLPA did not reveal any exon deletions or duplications in any of the patients. CONCLUSION: This is the first report of IRF6 analysis in an IGHD cohort. We found one new mutation which, based on in silico analysis, could be of functional relevance. However, we did not find any mutations in the other patients. Therefore, we conclude that IRF6 defects are rare in IGHD patients and further research should focus on new candidate genes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11102-017-0808-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5606942
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-56069422017-10-04 Genetic analysis of IRF6, a gene involved in craniofacial midline formation, in relation to pituitary and facial morphology of patients with idiopathic growth hormone deficiency Starink, Eline Hokken-Koelega, Anita C. S. Visser, Theo J. Baan, Janneke Peeters, Robin P. de Graaff, Laura C. G. Pituitary Article INTRODUCTION: Growth hormone is secreted by the pituitary gland, which forms part of the craniofacial midline. IRF6 encodes a transcription factor involved in the development of the craniofacial midline and mutations in IRF6 are known to disturb craniofacial development. Craniofacial and pituitary development are closely related. After whole exome sequencing revealed a new mutation in IRF6 in a family with Idiopathic Growth Hormone Deficiency (IGHD), we screened the remainder of our IGHD cohort for mutations in this gene and related their genotypes to pituitary and craniofacial morphology. MATERIALS AND METHODS: We sequenced all coding exons and exon–intron boundaries of IRF6 in 81 patients with IGHD. We performed a multiplex ligation-dependent probe amplification (MLPA) in order to exclude copy number variations in IRF6. We analyzed facial measurements taken from standardized digital pictures of 48 patients. RESULTS: We found two new variants and eleven polymorphisms. Apart from the new mutation found in the index family (p.Arg233Cys), we found one other new heterozygous missense mutation in IRF6 (Pro456Ser). p.Arg233Cys was reported as extremely rare in exome databases (1 allele out of 120.852 alleles sequenced), strictly conserved among species and was predicted deleterious by all variant predictor programs. Pro456Ser was predicted to be benign. MLPA did not reveal any exon deletions or duplications in any of the patients. CONCLUSION: This is the first report of IRF6 analysis in an IGHD cohort. We found one new mutation which, based on in silico analysis, could be of functional relevance. However, we did not find any mutations in the other patients. Therefore, we conclude that IRF6 defects are rare in IGHD patients and further research should focus on new candidate genes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11102-017-0808-8) contains supplementary material, which is available to authorized users. Springer US 2017-06-07 2017 /pmc/articles/PMC5606942/ /pubmed/28593555 http://dx.doi.org/10.1007/s11102-017-0808-8 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Starink, Eline
Hokken-Koelega, Anita C. S.
Visser, Theo J.
Baan, Janneke
Peeters, Robin P.
de Graaff, Laura C. G.
Genetic analysis of IRF6, a gene involved in craniofacial midline formation, in relation to pituitary and facial morphology of patients with idiopathic growth hormone deficiency
title Genetic analysis of IRF6, a gene involved in craniofacial midline formation, in relation to pituitary and facial morphology of patients with idiopathic growth hormone deficiency
title_full Genetic analysis of IRF6, a gene involved in craniofacial midline formation, in relation to pituitary and facial morphology of patients with idiopathic growth hormone deficiency
title_fullStr Genetic analysis of IRF6, a gene involved in craniofacial midline formation, in relation to pituitary and facial morphology of patients with idiopathic growth hormone deficiency
title_full_unstemmed Genetic analysis of IRF6, a gene involved in craniofacial midline formation, in relation to pituitary and facial morphology of patients with idiopathic growth hormone deficiency
title_short Genetic analysis of IRF6, a gene involved in craniofacial midline formation, in relation to pituitary and facial morphology of patients with idiopathic growth hormone deficiency
title_sort genetic analysis of irf6, a gene involved in craniofacial midline formation, in relation to pituitary and facial morphology of patients with idiopathic growth hormone deficiency
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606942/
https://www.ncbi.nlm.nih.gov/pubmed/28593555
http://dx.doi.org/10.1007/s11102-017-0808-8
work_keys_str_mv AT starinkeline geneticanalysisofirf6ageneinvolvedincraniofacialmidlineformationinrelationtopituitaryandfacialmorphologyofpatientswithidiopathicgrowthhormonedeficiency
AT hokkenkoelegaanitacs geneticanalysisofirf6ageneinvolvedincraniofacialmidlineformationinrelationtopituitaryandfacialmorphologyofpatientswithidiopathicgrowthhormonedeficiency
AT vissertheoj geneticanalysisofirf6ageneinvolvedincraniofacialmidlineformationinrelationtopituitaryandfacialmorphologyofpatientswithidiopathicgrowthhormonedeficiency
AT baanjanneke geneticanalysisofirf6ageneinvolvedincraniofacialmidlineformationinrelationtopituitaryandfacialmorphologyofpatientswithidiopathicgrowthhormonedeficiency
AT peetersrobinp geneticanalysisofirf6ageneinvolvedincraniofacialmidlineformationinrelationtopituitaryandfacialmorphologyofpatientswithidiopathicgrowthhormonedeficiency
AT degraafflauracg geneticanalysisofirf6ageneinvolvedincraniofacialmidlineformationinrelationtopituitaryandfacialmorphologyofpatientswithidiopathicgrowthhormonedeficiency